Neopath (NPTH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neopath (NPTH)

NPTH 0.000600

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cuong Huy Nguyen who wrote (1)	3/30/1997 6:50:00 PM
From: MED TECH	of 178

Cuong, Check out SE 10Q listing of NPTH, it is very extensive. I doubt that it will get approved that soon; but after approval the sales will really hit the roof. We currently have an accute shortage in cytotechnologists, also people get burned out in the field. How do you put up with staring at the microscope 8 hours/day ?? An instrument to automate the process will really enhance the whole thing leaving time for the techs to do other stuff and reducing eye strain. Personnally, I will follow this stock and buy further down the road when approval is more imminent. NPTH does have a good market outside this country though; earnings should be stable but spectacular price is still months away. Good investment, not good for quick return. MT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next